Androgen Treatment Effects on Motor Function, Cognition, and Behavior in Boys with Klinefelter Syndrome - 14/12/17
, Harvey Kushner, PhD 3, Karen Kowal, PA 1, 2, Martha Bardsley, MD 1, 2, Shanlee Davis, MD 4, Allan L. Reiss, MD 5, Nicole Tartaglia, MD 4, David Roeltgen, MD 6Abstract |
Objectives |
To examine the effects of early low-dose androgen on motor, cognitive, and behavioral function in prepubertal boys with Klinefelter syndrome (47,XXY).
Study design |
Double-blind trial of 84 boys, ages 4-12 years, randomized to oxandrolone (Ox; 0.06 mg/kg daily; n = 43) or placebo (Pl; n = 41) for 24 months. Standardized assessments were performed at baseline and every 12 months for 24 months evaluating motor, cognitive, and behavioral function.
Results |
The 24-month outcomes were better in the Ox vs. Pl group on 1 of 5 primary endpoints (motor function/strength): Bruininks Visual-Motor scale (P = .005), without significant differences between the 2 groups for the other 4 components. Secondary analyses suggested improvement in the Ox vs. Pl group in the anxiety/depression (P = .03) and social problems (P = .01) scales on the Child Behavior Checklist, anxiety (P = .04) on the Piers Harris Self Concept Scale, and interpersonal problems (P = .02) on the Children's Depression Inventory, without significant differences in hyperactive or aggressive behaviors.
Conclusions |
This double-blind, randomized trial demonstrates that 24 months of childhood low-dose androgen treatment in boys with Klinefelter syndrome benefited 1 of 5 primary endpoints (visual-motor function). Secondary analyses demonstrated positive effects of androgen on aspects of psychosocial function (anxiety, depression, social problems), without significant effects on cognitive function, or hyperactive or aggressive behaviors.
Trial registration |
ClinicalTrials.gov: NCT00348946.
Le texte complet de cet article est disponible en PDF.Keywords : Klinefelter syndrome, 47,XXY Child, androgen, randomized controlled trial, testicular function, gonadal failure, United States, longitudinal studies, sex chromosome disorders, sex chromosome aneuploidy, sex chromosome variations
Abbreviations : AR, BOT, CBCL, DAS-II, OX, Pl, SES
Plan
| Supported by the National Institute of Neurological Disorders and Stroke (NINDS) (NS050597). N.T. is supported by NINDS (K23NS070337). The authors declare no conflicts of interest. |
Vol 185
P. 193 - juin 2017 Retour au numéro
Article précédent
- Health Disparities in the Appropriate Management of Cryptorchidism
- Kate B. Savoie, Marielena Bachier-Rodriguez, Elleson Schurtz, Elizabeth A. Tolley, Dana Giel, Alexander Feliz
- Who to Refer for Speech Therapy at 4 Years of Age Versus Who to “Watch and Wait”?
- Angela Morgan, Kyriaki Ttofari Eecen, Angela Pezic, Katherine Brommeyer, Cristina Mei, Patricia Eadie, Sheena Reilly, Barbara Dodd
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?